As of close of business last night, Larimar Therapeutics Inc’s stock clocked out at $8.70, up 0.06% from its previous closing price of $8.69. In other words, the price has increased by $+0.01 from its previous closing price. On the day, 665867 shares were traded.
Ratios:
To gain a deeper understanding of LRMR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.49 and its Current Ratio is at 9.49. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On October 19, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 16 ’24 when Flynn James E bought 4,290,617 shares for $8.74 per share. The transaction valued at 37,499,993 led to the insider holds 6,151,406 shares of the business.
THOMAS FRANK E bought 2,000 shares of LRMR for $22,000 on Feb 14 ’24. The Director now owns 2,000 shares after completing the transaction at $11.00 per share. On Dec 07 ’23, another insider, Shankar Gopi, who serves as the Chief Development Officer of the company, bought 5,000 shares for $3.73 each. As a result, the insider paid 18,662 and bolstered with 5,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 553.08M and an Enterprise Value of 471.84M.
Stock Price History:
Over the past 52 weeks, LRMR has reached a high of $13.68, while it has fallen to a 52-week low of $2.18. The 50-Day Moving Average of the stock is 7.87, while the 200-Day Moving Average is calculated to be 4.66.
Shares Statistics:
It appears that LRMR traded 536.49K shares on average per day over the past three months and 605.76k shares per day over the past ten days. A total of 43.91M shares are outstanding, with a floating share count of 25.84M. Insiders hold about 41.14% of the company’s shares, while institutions hold 64.47% stake in the company. Shares short for LRMR as of Feb 29, 2024 were 506.81k with a Short Ratio of 0.94, compared to 339.7k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.80% and a Short% of Float of 1.11%.
Earnings Estimates
As of right now, 4 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.28 for the current quarter, with a high estimate of -$0.19 and a low estimate of -$0.34, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.29 and low estimates of -$0.41.
Analysts are recommending an EPS of between -$1.28 and -$1.73 for the fiscal current year, implying an average EPS of -$1.47. EPS for the following year is -$1.85, with 3 analysts recommending between -$1.32 and -$2.29.
